Literature DB >> 26524077

Quality of Life, Emotional Wellbeing and Family Repercussions in Dermatological Patients Experiencing Chronic Itching: A Pilot Study.

Servando E Marron1, Lucia Tomas-Aragones, Santiago Boira, Ricardo Campos-Rodenas.   

Abstract

A better understanding of the psychosocial impact of chronic itching could lead to improved intervention strategies. The aim of this study is to examine the prevalence and characteristics of chronic itching in dermatological patients. The Itch Severity Scale (ISS) was completed by a sample of 201 patients from a Dermatology Outpatient Clinic in Spain and 61.69% (n = 124) of participants recorded a positive score (X = 8.89, DT = 4.06). The results indicate that chronic itching has significant psychosocial repercussions. The Dermatology Life Quality Index (DLQI) showed that the negative impact on quality of life was significantly greater for the group that experienced chronic itching (p < 0.001). Scores on the Anxiety and Depression Scale (HADS) revealed that the group with chronic itching had more symptoms associated with anxiety (p = 0.001). The Family APGAR found no statistically significant differences between the groups with regards to repercussions on the family dynamic.

Entities:  

Mesh:

Year:  2016        PMID: 26524077     DOI: 10.2340/00015555-2263

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  [Pruritus in Germany-a Google search engine analysis].

Authors:  A Zink; M Rüth; B Schuster; U Darsow; T Biedermann; S Ständer
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

Review 2.  Psychologic interventions in patients with the chronic dermatologic itch in atopic dermatitis and psoriasis: A step forward with family constellations seminars.

Authors:  Szergej Capec; Martin Petrek; Gabriella Capec; Roman Yaremkevych; Yuriy Andrashko
Journal:  Front Med (Lausanne)       Date:  2022-08-12

Review 3.  Mechanisms and Management of Itch in Dry Skin.

Authors:  Catharina Sagita Moniaga; Mitsutoshi Tominaga; Kenji Takamori
Journal:  Acta Derm Venereol       Date:  2020-01-15       Impact factor: 3.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.